IBN

    Mobilicom (NASDAQ: MOB) is a provider of robust end-to-end hardware and software solutions for defense and commercial drones, robotics, and autonomous systems. The company serves original equipment manufacturers (“OEMs”) seeking to keep unmanned platforms connected, protected, and operational during demanding

    Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company operating a contract development and manufacturing organization (“CDMO”) alongside an immunotherapy development platform, announced securities purchase and warrant inducement agreements with an existing institutional investor expected to generate approximately $4 million in aggregate